<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03474952</url>
  </required_header>
  <id_info>
    <org_study_id>RIPC during free flap</org_study_id>
    <nct_id>NCT03474952</nct_id>
  </id_info>
  <brief_title>Effects of Remote Ischemic Preconditioning During Free Flap Reconstruction</brief_title>
  <official_title>Effects of Remote Ischemic Preconditioning During Free Flap Reconstruction in Head and Neck Cancer Patients: a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Remote ischemic preconditioning (RIPC) has been revealed organ-protective effect in many
      previous clinical settings including coronary intervention or cardiovascular surgery. However
      its protective role during free flap reconstructive surgery in head and neck cancer patients
      has not yet been elucidated. The purpose of the current study is to evaluate the effect of
      RIPC on tissue oxygen saturation and skin temperature of the flap, as well as its
      organ-protective effect using Langendorff isolated heart ischemia-reperfusion model.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients undergoing free flap reconstructive surgery for head and neck cancer will be
      randomized to either remote ischemic preconditioning (RIPC) group or control group. On the
      day of surgery, after induction of anesthesia, RIPC, consisting of 4 cycles of 5-min ischemia
      (using pneumatic cuff pressure of 200 mmHg) followed by 5-min reperfusion at upper arm, or
      sham-RIPC (pressure &lt; 10 mmHg) will be induced in the RIPC or control group, respectively.
      Before completion of surgery, RIPC or sham-RIPC will be repeated. Tissue oxygen saturation
      and skin temperature of the flap will be recorded until postoperative day 1.

      As a sub-study, blood samples will be obtained before and after RIPC/sham-RIPC. From them,
      plasma dialysate will be prepared to use for Langendorff isolated heart model. Myocardial
      infarct size of Langendorff rat heart will be compared between the groups to evaluate organ
      protective effect of RIPC during free flap reconstuctive surgery.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 13, 2018</start_date>
  <completion_date type="Anticipated">March 20, 2019</completion_date>
  <primary_completion_date type="Anticipated">February 21, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>RIPC group and control (sham-RIPC) group</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>tissue oxygen saturation</measure>
    <time_frame>postoperative day 1</time_frame>
    <description>tissue oxygen saturation of free flap</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Remote Ischemic Preconditioning</condition>
  <arm_group>
    <arm_group_label>Remote ischemic preconditioning (RIPC)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intervention is remote ischemic preconditioning (RIPC) consists of 4 cycles of 5-min ischemia (using pneumatic cuff pressure of 200 mmHg) and subsequent 5-min reperfusion applied to upper arm.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control (Sham-RIPC)</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Intervention is Sham-RIPC (ischemia pressure &lt; 10 mmHg) applied to upper arm.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>remote ischemic preconditioning (RIPC)</intervention_name>
    <description>remote ischemic preconditioning consists of 4 cycles of 5-min ischemia and subsequent 5-min reperfusion using pneumatic cuff applied to upper arm</description>
    <arm_group_label>Remote ischemic preconditioning (RIPC)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>sham-RIPC</intervention_name>
    <description>ischemia pressure less than 10 mmHg (sham-RIPC)</description>
    <arm_group_label>Control (Sham-RIPC)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients undergoing free flap reconstructive surgery

        Exclusion Criteria:

          -  BMI &lt; 18, &gt; 35 kg/m^2

          -  AV fistula at arm, any reason to protect arm

          -  vascular abnormality or discomfort at arm

          -  peripheral vascular disease, peripheral neuropathy, or coagulopathy

          -  uncontrolled diabetes mellitus

          -  preoperative use of beta-blocker

          -  history of radiation therapy

          -  refuse to enrol
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Youn Joung Cho, MD</last_name>
    <phone>82-2-2072-2467</phone>
    <email>mingming7@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>03080</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Youn Joung Cho, MD</last_name>
      <phone>82-2-2072-3108</phone>
      <email>mingming7@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Karam Nam, MD</last_name>
      <phone>82-2-2072-2469</phone>
      <email>karamnam@gmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 14, 2018</study_first_submitted>
  <study_first_submitted_qc>March 21, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 23, 2018</study_first_posted>
  <last_update_submitted>April 16, 2018</last_update_submitted>
  <last_update_submitted_qc>April 16, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 18, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>remote ischemic preconditioning</keyword>
  <keyword>free flap reconstruction</keyword>
  <keyword>tissue oxygen saturation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ischemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

